KMPHARMACEUTICAL Co.,Ltd.

A225430

KR7225430008

Personal Products

End-of-day quote Korea S.E. Other stock markets 18:00:00 2024-05-30 EDT			5-day change	1st Jan Change
792 ^KRW	-1.00%		-1.74%	-19.02%

2018	Km Pharmaceutical Co., Ltd. completed the acquisition of IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction.	CI
2018	IBKS No.3 Special Purpose Acquisition Company‘s Equity Buyback announced on March 1, 2018, has expired.	CI

K Investment Co., Ltd. acquired 1% stake in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for approximately KRW 500 million.

May 22, 2017

K Investment Co., Ltd. acquired 1% stake in Km Pharmaceutical Co., Ltd. (XKON:A237720) from Mun, Sung Keun for approximately KRW 500 million on May 17, 2017. As per terms, 22,000 shares are acquired at KRW 22,600 per share. K Investment Co., Ltd. completed the acquisition of 1% stake in Km Pharmaceutical Co., Ltd. (XKON:A237720) from Mun, Sung Keun on May 17, 2017.

Latest news about KMPHARMACEUTICAL Co.,Ltd.

Km Pharmaceutical Co., Ltd. completed the acquisition of IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction.	18-09-11	CI
IBKS No.3 Special Purpose Acquisition Company‘s Equity Buyback announced on March 1, 2018, has expired.	18-08-01	CI
Sungkeun Mun acquired 4.9% stake in Km Pharmaceutical Co., Ltd. from K Investment Co., Ltd., Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73, and KTB Mezzanine Private Investment Trust No. 74, funds managed by KTB Asset Management Co., Ltd for KRW 2.7 billion.	18-04-19	CI
Km Pharmaceutical Co., Ltd. cancelled the acquisition of 4% in Iconix Co., Ltd. from Wonjung Kim, Hyunsoo Seo, Changhwan Shin, Youngsik Im and Miyoung Jung.	18-04-19	CI
Km Pharmaceutical Co., Ltd. announces an Equity Buyback.	18-03-01	CI
Km Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	18-02-27	CI
Km Pharmaceutical Co., Ltd. entered into an agreement to acquire IBKS No.3 Special Purpose Acquisition Company in a reverse merger transaction.	18-02-27	CI
K Investment Co., Ltd. acquired 1% stake in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for approximately KRW 500 million.	17-05-22	CI
Juyong Shin acquired 0.18% stake in Km Pharmaceutical Co., Ltd. from Sung Keun Mun for KRW 90.4 million.	17-05-22	CI
Shinhan Investment Corp., KTB Growth Industry Hedge Fund, KTB Mezzanine Private Investment Trust No. 73 and KTB Mezzanine Private Investment Trust No. 74 funds managed by KTB Asset Management Co., Ltd acquired 3.92% in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for KRW 2 billion.	17-05-22	CI
Km Pharmaceutical Co., Ltd. signed a contract to acquire 4% in Iconix Co., Ltd. from Wonjung Kim, Hyunsoo Seo, Changhwan Shin, Youngsik Im and Miyoung Jung for KRW 4 billion.	17-04-20	CI
ST Capital Co., Ltd and Youngin Seo acquired 0.15% stake in Km Pharmaceutical Co., Ltd from Sunggeun Moon for KRW 75 million.	16-12-27	CI
ST Capital Co., Ltd acquired an additional 0.25% stake in Km Pharmaceutical Co., Ltd from Sunggeun Mun for approximately KRW 130 million.	16-12-27	CI
ST Capital Co., Ltd and Youngin Seo acquired 0.74% stake in Km Pharmaceutical Co., Ltd from Sunggeun Moon for approximately KRW 380 million.	16-12-01	CI
Sunggeun Moon sold 0.79% stake in Km Pharmaceutical Co., Ltd. for KRW 400 million.	16-10-13	CI
2014 SV-Growth Ladder Gap Coverage Fund, a fund of SV Investment Corp. acquired 5.93% stake in Km Pharmaceutical Co., Ltd. from Kang, Il-Mo and Moon, Sunggeun for KRW 3 billion.	16-09-22	CI
Seo Seunghee acquired 0.2% stake in Km Pharmaceutical Co., Ltd. from Il-Mo Kang for KRW 100 million.	16-09-01	CI
Youngchan Min acquired 0.49% stake in Km Pharmaceutical Co., Ltd from Il-Mo Kang for KRW 250 million.	16-09-01	CI
Youngchan Min acquired 1.38% stake in Km Pharmaceutical Co., Ltd from Il-Mo Kang for KRW 700 million.	16-06-29	CI
Youngchan Min acquired 0.99% stake in Km Pharmaceutical Co., Ltd from Il-Mo Kang for KRW 500 million.	16-06-28	CI

Chart KMPHARMACEUTICAL Co.,Ltd.

Duration

Period

More charts

Company Profile

KMPharmaceutical Co Ltd is a Korea-based company principally engaged in the manufacture and sale of personal products. The Company is principally engaged in the manufacture and sale of oral hygiene products such as toothpaste, toothbrushes and gargles for children and adults. The Company is engaged in the manufacture and sale of beauty care products such as shampoo, body wash, cosmetics as well as other daily necessities. In addition, the Company is also engaged in the real estate leasing.

Sector

Personal Products

More about the company

Sector Other Personal Products

	1st Jan change	Capi.
KMPHARMACEUTICAL CO.,LTD.	-19.02%	15.97M
PROCTER & GAMBLE COMPANY	+12.28%	388B
UNILEVER PLC	+12.61%	136B
COLGATE-PALMOLIVE COMPANY	+16.62%	76.27B
HINDUSTAN UNILEVER LIMITED	-12.57%	65.56B
ESTEE LAUDER	-15.65%	44.23B
KENVUE INC.	-10.36%	36.96B
BEIERSDORF	+6.37%	35.04B
ESSITY AB	+7.80%	18.02B
GODREJ CONSUMER PRODUCTS LIMITED	+12.30%	15.57B

Other Personal Products

KMPHARMACEUTICAL Co.,Ltd.

Equities

A225430

KR7225430008

Personal Products

K Investment Co., Ltd. acquired 1% stake in Km Pharmaceutical Co., Ltd. from Mun, Sung Keun for approximately KRW 500 million.

Latest news about KMPHARMACEUTICAL Co.,Ltd.

Chart KMPHARMACEUTICAL Co.,Ltd.

Company Profile

Sector Other Personal Products